Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05690464
NA

Effect of Magnesium Supplementation on Elevated Systolic Blood Pressure

Sponsor: Brigham and Women's Hospital

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess whether 480 mg/day magnesium glycinate supplementation for 12 weeks lowers blood pressure.

Official title: Trial of Magnesium Supplementation and Blood Pressure Reduction Among Adults With Elevated Systolic Blood Pressure

Key Details

Gender

All

Age Range

30 Years - 74 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2023-01-17

Completion Date

2026-05

Last Updated

2025-12-23

Healthy Volunteers

Yes

Conditions

Interventions

DIETARY_SUPPLEMENT

magnesium glycinate supplement

magnesium glycinate (480 mg/day)

DIETARY_SUPPLEMENT

placebo

placebo

Locations (1)

Brigham and Women's Hospital

Boston, Massachusetts, United States